950 results on '"Mestroni, Luisa"'
Search Results
2. Abstract 4147845: Valsartan and Cardiac Remodeling in Early-Stage Hypertrophic Cardiomyopathy: The VANISH Trial Cardiac Magnetic Resonance Substudy
3. Abstract 4142400: Clinical implication and potential role of immunosuppression for myocarditis episodes in patients with desmoplakin cardiomyopathy: hope from the DSP-ERADOS Network?
4. Abstract 4141605: Genetic Determinant for Prognosis of Dilated Cardiomyopathy: The role of NAV3 in Cardiac Fibrosis
5. Abstract 4140148: Genetic Influence in Patients Transplanted for Myocarditis in the TOPMed-TOPCHeF Cohort of Explanted Hearts
6. Abstract 4137272: The Impact of Genotype in Dilated and Arrhythmogenic Cardiomyopathy: Insights from the SHaRE Registry
7. A Systematic Analysis of the Clinical Outcome Associated with Multiple Reclassified Desmosomal Gene Variants in Arrhythmogenic Right Ventricular Cardiomyopathy Patients
8. Neonatal rat ventricular myocytes interfacing conductive polymers and carbon nanotubes
9. Impact of DCM-Causing Genetic Background on Long-Term Response to Cardiac Resynchronization Therapy
10. Investigations of cardiac fibrosis rheology by in vitro cardiac tissue modeling with 3D cellular spheroids
11. A genetic association study of circulating coagulation factor VIII and von Willebrand factor levels
12. Long-Term Arrhythmic Follow-Up and Risk Stratification of Patients With Desmoplakin-Associated Arrhythmogenic Right Ventricular Cardiomyopathy
13. Innate immune signaling in hearts and buccal mucosa cells of patients with arrhythmogenic cardiomyopathy
14. Epigenome-wide DNA methylation association study of circulating IgE levels identifies novel targets for asthma
15. Multicenter clinical and functional evidence reclassifies a recurrent noncanonical filamin C splice-altering variant
16. Abstract 16898: Myocardial Recovery Associated Gene Cdcp1 Expression Attenuates Cardiac Fibrosis in a Pressure Over-Load Mouse Model
17. Abstract 16714: An Injectable Thermo-Responsive Hydrogel as a Tool for Cardiac Tissue Engineering Efforts: In vitro and in vivo Biocompatibility Assessment
18. Abstract 14249: Sex and Gene Based Differences in Age Related Penetrance of Dilated and Arrhythmogenic Cardiomyopathy
19. Abstract 14213: A Retrospective Natural History Study of Danon Disease
20. Abstract 12135: Quality of Life in Early-Stage Hypertrophic Cardiomyopathy: A Secondary Analysis of the VANISH Trial
21. Myocardial Injury and Altered Gene Expression Associated With SARS-CoV-2 Infection or mRNA Vaccination
22. Altered microtubule structure, hemichannel localization and beating activity in cardiomyocytes expressing pathologic nuclear lamin A/C.
23. Ankyrin-B dysfunction predisposes to arrhythmogenic cardiomyopathy and is amenable to therapy
24. Long-Term Efficacy and Safety of ARRY-371797 (PF-07265803) in Patients With Lamin A/C–Related Dilated Cardiomyopathy
25. Regulation of extracellular matrix composition by fibroblasts during perinatal cardiac maturation
26. AFM macro-probes to investigate whole 3D cardiac spheroids
27. Microfabricated cantilevers for parallelized cell-cell adhesion measurements
28. Biomechanical defects and rescue of cardiomyocytes expressing pathologic nuclear lamins
29. An International Longitudinal Natural History Study of Danon Disease Patients: Unique Cardiac Trajectories Identified Based on Sex and Heart Failure Outcomes
30. Y chromosome linked UTY modulates sex differences in valvular fibroblast methylation in response to nanoscale extracellular matrix cues
31. Clinical and genetic features of arrhythmogenic cardiomyopathy: diagnosis, management and the heart failure perspective
32. Prevalence and Evolution of Right Ventricular Dysfunction Among Different Genetic Backgrounds in Dilated Cardiomyopathy
33. The genetic architecture of Plakophilin 2 cardiomyopathy
34. Antiarrhythmic therapy and risk of cumulative ventricular arrhythmias in arrhythmogenic right ventricle cardiomyopathy
35. Right precordial-directed electrocardiographical markers identify arrhythmogenic right ventricular cardiomyopathy in the absence of conventional depolarization or repolarization abnormalities.
36. Injectable Carbon Nanotube-Functionalized Reverse Thermal Gel Promotes Cardiomyocytes Survival and Maturation
37. Quality of Life and Exercise Capacity in Early Stage and Subclinical Hypertrophic Cardiomyopathy: A Secondary Analysis of the VANISH Trial.
38. Transcriptome signature of ventricular arrhythmia in dilated cardiomyopathy reveals increased fibrosis and activated TP53
39. Defective Biomechanics and Pharmacological Rescue of Human Cardiomyocytes with Filamin C Truncations
40. Filamin C Deficiency Impairs Sarcomere Stability and Activates Focal Adhesion Kinase through PDGFRA Signaling in Induced Pluripotent Stem Cell-Derived Cardiomyocytes
41. Biomimetic Polymers for Cardiac Tissue Engineering
42. A novel tool for arrhythmic risk stratification in desmoplakin gene variant carriers
43. Long-Term Arrhythmic Follow-Up and Risk Stratification of Patients With Desmoplakin-Associated Arrhythmogenic Right Ventricular Cardiomyopathy
44. Genetics of Dilated Cardiomyopathy: Current Knowledge and Future Perspectives
45. Historical Terminology, Classifications, and Present Definition of DCM
46. AFM single-cell force spectroscopy links altered nuclear and cytoskeletal mechanics to defective cell adhesion in cardiac myocytes with a nuclear lamin mutation
47. The Cardiomyopathy Lamin A/C D192G Mutation Disrupts Whole-Cell Biomechanics in Cardiomyocytes as Measured by Atomic Force Microscopy Loading-Unloading Curve Analysis.
48. 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy: Executive summary
49. Carbon Nanotubes for Cardiac Applications
50. Genetics of Dilated Cardiomyopathy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.